Theranostics is moving beyond oncology — and IMV’s latest PET Census data shows exactly where adoption is shifting. Download the free snapshot pdf.

Radiopharmaceuticals are experiencing a renaissance. From precision oncology with lutetium-177-based therapies to increasing demand for diagnostic procedures performed daily in the U.S., nuclear medicine has never been more clinically vital. However, beneath this wave of…

For decades, diagnostic imaging manufacturers have anchored their growth strategies to clinical demand, capital cycles, and incremental modality innovation. However, a quieter (and potentially more disruptive) shift is now underway upstream in the life sciences.…

The U.S. diagnostic imaging market is valued at approximately $150 billion in 2025 and encompasses an estimated 600 million or more procedures annually. But where a scan is performed matters enormously — for the patient’s…

The diagnostic imaging industry is continuing to see significant technological innovation. Across CT, MRI, and ultrasound, OEMs are bringing innovations to market that don’t just improve image quality — they have the potential to change…